Home News Pfizer sets thanks to Wyeth-over in the 4th Quarter profit jump out

Pfizer sets thanks to Wyeth-over in the 4th Quarter profit jump out

427
0

2009_03_12_pfizer_comp NEW YORK (Dow Jones) – U.S. pharmaceutical company Pfizer in the fourth quarter deserves a lot more and a little more implemented. (Picture: Pfizer)

Benefited from the group here in October 2009 completed acquisition of competitor Wyeth and lower restructuring costs in connection with the acquisition. Like Pfizer Inc announced on Tuesday its net profit climbed to a rise by 6% to 17.56 billion USD in sales to 2.89 billion USD. He is a previous value of just over 767 million USD. In addition, the Group announced a forecast for 2011 and adjusted its expectations for 2012.
Earnings per share amounted to 0.36, the company (previous year: 0.10) USD. Adjusted, diluted earnings per share was 0.47 (0.49) are to USD. The consensus estimate of analysts surveyed by Thomson Reuters had been denominated in $ 0.46 per share. In terms of sales, market observers the company had 16.99 billion USD credit for.
Based on the full year 2010, Pfizer has indeed implemented much more, but the bottom line earning less. Their annual forecasts, the Group has fulfilled yet, in some cases even exceeded. 1.02 (1.23) USD, the earnings per share over the expected range of $ 0.84 to 0.94 USD. The same was the pharmaceutical company also adjusted, diluted earnings per share of 2.23 (2.02) USD, which is facing its own forecast range of $ 2.17 to $ 2.22. Only with the submitted annual turnover of 67.81 (50.01) billion, Pfizer has its own estimate of 67 billion to 68 billion USD "just" met. Net earnings in 2010 decreased to 8.25 (8.64) billion.
For the current year is Pfizer sales of between 66 billion and 68 billion USD in view. Earnings per share are seen between $ 1.09 and $ 1.24 per share, while the forecast is for adjusted, diluted earnings per share certificate to a range of $ 2.16 to 2.26 USD.
Its sales forecast for 2012 has reduced Pfizer, confirmed its earnings expectations, however. The company now expects to implement in the coming year of between 63 billion and 65.5 billion USD to be able to. So far, the New York sales between 65.2 billion and 67.7 billion U.S. dollars had been promised. Earnings per share of $ 1.58 to $ 1.73 or $ 2.25 adjusted to 2.35 USD was confirmed.